Skip to main content
OUTCOME
3.2
Communicable diseases, antimicrobial resistance, and immunization
Accelerate the disease elimination agenda and better prevent and treat communicable diseases, noncommunicable diseases, and mental health conditions
PB
2026-2027
Communicable diseases, antimicrobial resistance, and immunization
3.2. Prevention, control, and elimination of communicable diseases and related conditions accelerated and sustained
Budget
Approved Budget PB (Previous)
127.3
US$ MILLION
Priority

High

Proposed Budget PB (Current)
122.4
US$ MILLION
Related Outputs and Indicators
  • 3.2.1.a Number of countries and territories provided with technical cooperation to develop and implement national norms, standards, and tools aligned with PAHO and WHO guidelines on tuberculosis, HIV, viral hepatitis, and sexually transmitted infections
    Baseline
    10
    Target
    14
  • 3.2.1.b Number of countries and territories that have implemented a national envenoming program (venomous animals)
    Baseline
    2
    Target
    15
  • 3.2.1.c Number of countries and territories that have implemented integrated actions to prioritize zoonotic diseases
    Baseline
    4
    Target
    13
  • 3.2.2.a Number of countries and territories provided with technical cooperation to develop implementation plans for multidisease elimination in line with PAHO Disease Elimination Initiative
    Baseline
    2
    Target
    33
  • 3.2.2.b(a) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on the applicable PAHO/WHO elimination protocols (Trachoma)
    Baseline
    0
    Target
    2
  • 3.2.2.b(b) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on the applicable PAHO/WHO elimination protocols (Yaws)
    Baseline
    0
    Target
    9
  • 3.2.2.b(c) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on the applicable PAHO/WHO elimination protocols (Leprosy)
    Baseline
    0
    Target
    4
  • 3.2.2.b(d) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on the applicable PAHO/WHO elimination protocols (Lymphatic filariasis)
    Baseline
    2
    Target
    2
  • 3.2.2.b(e) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on the applicable PAHO/WHO elimination protocols (Onchocerciasis)
    Baseline
    3
    Target
    3
  • 3.2.2.b(f) Number of previously endemic countries or territories that have initiated the process to validate or verify the elimination of one or more neglected tropical diseases, based on the applicable PAHO/WHO elimination protocols (Human Rabies transmitted by dogs)
    Baseline
    1
    Target
    14
  • 3.2.2.c Number of countries and territories expanding access to malaria diagnosis and treatment with participation of the affected communities or general health services
    Baseline
    4
    Target
    18
  • 3.2.3.a Number of countries and territories provided with technical cooperation for the preparation of elimination of mother-to-child transmission roadmaps
    Baseline
    7
    Target
    25
  • 3.2.3.b Number of countries implementing the clinical bundle for the care of patients with suspected arboviral diseases
    Baseline
    8
    Target
    10
  • 3.2.3.c Number of countries and territories that implement person-centered strategies and point of care technologies for the elimination of HIV and tuberculosis
    Baseline
    1
    Target
    9
  • 3.2.4.a Number of countries and territories provided with technical cooperation to support reporting on WHO recommended indicators for HIV, tuberculosis, viral hepatitis and selected sexually transmitted infections
    Baseline
    3
    Target
    13
  • 3.2.4.b Number of countries and territories that have implemented foodborne disease surveillance systems
    Baseline
    1
    Target
    5
  • 3.2.5.a Number of countries and territories implementing antimicrobial resistance awareness, education, and behavior change interventions, with a focus on key populations and community engagement
    Baseline
    5
    Target
    25
  • 3.2.5.b Number of countries and territories that have institutionalized national programs for infection prevention and control and/or antimicrobial stewardship as part of antimicrobial resistance containment effort
    Baseline
    4
    Target
    15
  • 3.2.6.a Number of countries and territories provided with technical cooperation to implement PAHO tools for immunization program strengthening
    Baseline
    4
    Target
    21
  • 3.2.6.b Number of countries and territories implementing digital interoperable vaccine preventable disease surveillance systems
    Baseline
    3
    Target
    19